Master the Fiber 3×10 Rule, eat 10g fiber per meal, curb hunger fast, control cravings, support weight loss, and improve gut ...

Johnson & Johnson has launched its "Dual control" campaign in Asia Pacific, aiming to empower patients with inflammatory bowel disease (IBD) to manage their condition while pursuing life goals.

Crohn's disease (CD) and ulcerative colitis (UC), the two main forms of IBD, affect around 10 million people worldwide, and the number of patients is increasing in Asia[1],[2],[3]. Typically beginning ...

The clinical and molecular heterogeneity of IBD—both between patients and within the same individual over time—continues to ...

New IBD research shows that, even during clinical remission, people living with Crohn's disease continue to experience greater work impairment than the general population The new campaign aims to ...

Immunai collected a hefty $215 million series B round back in 2021 after raising $60 million through a series A earlier that same year. Those funds have helped the company stretch its reach from ...

The updated indication for the JAK inhibitor allows use in patients with moderately to severely active ulcerative colitis and ...

This review examines how Western dietary patterns, high in ultra-processed foods, salt, and unhealthy fats, disrupt gut ...

The Food and Drug Administration (FDA) has approved updated indications for Rinvoq® (upadacitinib) in the treatment of adults with moderately to severely active ulcerative colitis (UC) or Crohn ...